BOSCX
Price
$14.79
Change
-$1.23 (-7.68%)
Updated
Apr 3 closing price
Net Assets
63.07M
VSCAX
Price
$20.55
Change
-$1.97 (-8.75%)
Updated
Apr 3 closing price
Net Assets
6.34B
Ad is loading...

BOSCX vs VSCAX

Header iconBOSCX vs VSCAX Comparison
Open Charts BOSCX vs VSCAXBanner chart's image
BNY Mellon Sm Cp Val C
Price$14.79
Change-$1.23 (-7.68%)
VolumeN/A
Net Assets63.07M
Invesco Small Cap Value A
Price$20.55
Change-$1.97 (-8.75%)
VolumeN/A
Net Assets6.34B
BOSCX vs VSCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BOSCX vs. VSCAX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOSCX is a Hold and VSCAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSCAX has more cash in the bank: 6.35B vs. BOSCX (63.1M). BOSCX pays higher dividends than VSCAX: BOSCX (0.70) vs VSCAX (0.37). BOSCX was incepted earlier than VSCAX: BOSCX (9 years) vs VSCAX (26 years). BOSCX (2.36) is less costly to investors than VSCAX (1.12). BOSCX is a more actively managed with annual turnover of: 44.75 vs. VSCAX (40.00). BOSCX (1000) and VSCAX (1000) have matching initial minimum investment requirements. VSCAX annual gain was more profitable for investors over the last year : -1.20 vs. BOSCX (-12.27). VSCAX return over 5 years is better than : 216.20 vs. BOSCX (37.35).
BOSCXVSCAXBOSCX / VSCAX
Total Expense Ratio2.211.12197%
Annual Report Gross Expense Ratio2.361.12211%
Fund Existence9 years26 years-
Gain YTD-4.586-4.211109%
Front LoadN/A6%-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets63.1M6.35B1%
Annual Yield % from dividends0.700.37192%
Returns for 1 year-12.27-1.201,020%
Returns for 3 years-27.2613.84-197%
Returns for 5 years37.35216.2017%
Returns for 10 years6.149.7763%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICTTX12.85N/A
N/A
ICON Health and Information Tech Inv
BRXSX13.75N/A
N/A
MFS Blended Research Intl Eq R2
DGEYX20.42N/A
N/A
BNY Mellon Global Emerging Mkts - Y
GAOTX20.20N/A
N/A
JPMorgan Global Allocation R3
CBFFX36.62-0.68
-1.82%
American Funds Global Balanced 529F1